TaxTMI Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All News
of of All News
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>Merck's Shares Drop 8% After Lower 2025 Sales Forecast; Gardasil Shipments to China Halted Until Mid-Year</h1> Merck's shares fell after announcing a lower-than-expected 2025 sales forecast, partly due to halting Gardasil vaccine shipments to China until mid-year. Gardasil sales dropped 17% to USD 1.55 billion in the last quarter, primarily from declining demand in China, despite recent approval for male use there. Merck projects 2025 earnings between USD 8.88 and USD 9.03 per share on sales of USD 64.1 billion to USD 65.6 billion, below analyst forecasts of USD 9.13 per share on USD 67.07 billion in sales. Keytruda sales rose 19% to USD 7.84 billion. Merck's shares decreased 8% to USD 91.61.
TaxTMI 
TaxTMI 
